Majorities see risks in AI and fewer see benefits.
Capital Group landed on two withdrawal strategies that depend on the retiree’s goals and expenses.
A latent class framework identified six treatment-pattern groups among women with breast cancer and classified held-out patients with 99.68% agreement against a Random Forest.
Rising diagnosed prevalence (about 170,000 US cases in 2025), wider JAK2/CALR molecular testing and the 2026 FDA approval of ropeginterferon alfa-2b drive growth in ET treatment across the US, EU4, UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results